Literature DB >> 36192664

Association of soluble cell adhesion molecules and lipid levels in rheumatoid arthritis patients.

Iris J Colunga-Pedraza1, Dionicio A Galarza-Delgado1, Natalia Guajardo-Jauregui2, Jesus A Cardenas-de la Garza1, Gisela Garcia-Arellano1, Rosa I Arvizu-Rivera1, Andrea N Garza-Cisneros1, Alexis Garcia-Heredia3, Mario A Balderas-Palacios1, Jose R Azpiri-Lopez4.   

Abstract

OBJECTIVES: To evaluate the relationship between soluble vascular cell adhesion molecule-1 (sVCAM-1), soluble intracellular adhesion molecule-1 (sICAM-1), and lipid levels in rheumatoid arthritis (RA) patients with and without carotid plaque (CP).
METHODS: Cross-sectional study nested of a RA cohort. RA patients without a previous cardiovascular event or statins' therapy, aged 40-75 years were recruited at an outpatient cardio-rheumatology clinic. Carotid ultrasound was performed in all study subjects. RA patients with CP were included and matched to RA patients without CP by age, gender, and traditional cardiovascular risk factors. Blood samples were drawn at the time of recruitment to measure sVCAM-1, sICAM-1, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), and lipid levels. Correlations between cell adhesion molecules, disease activity indexes, ESR and CRP with lipid levels were assessed with Spearman's correlation coefficient (rs).
RESULTS: We included 71 RA patients, 37 with CP and 34 without CP. RA (n = 71) patients had a moderate negative correlation of sVCAM-1 with total cholesterol (TC) (rs =  - 0.366, p = 0.002) and low-density lipoprotein (LDL) (rs =  - 0.316, p = 0.007), and a small negative correlation with high-density lipoprotein (rs =  - 0.250, p = 0.036). ESR showed a small negative correlation with LDL (rs =  - 0.247, p = 0.038). Patients with CP had a moderate negative correlation between sVCAM and TC (rs =  - 0.405, p = 0.013). Patients without CP showed a moderate negative correlation between sVCAM with TC (rs =  - 0.364, p = 0.034) and LDL (rs =  - 0.352, p = 0.041), and sICAM with VLDL (rs =  - 0.343, p = 0.047).
CONCLUSIONS: RA patients showed an inverse association of sVCAM-1 and lipid levels. More studies are needed to define the precise role of sVCAM-1 in the lipid paradox of RA.
© 2022. The Author(s), under exclusive licence to International League of Associations for Rheumatology (ILAR).

Entities:  

Keywords:  Atherosclerosis; Cardiovascular risk; Lipids; Rheumatoid arthritis; Vascular cell adhesion molecule-1

Year:  2022        PMID: 36192664     DOI: 10.1007/s10067-022-06395-6

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   3.650


  25 in total

Review 1.  The lipid paradox in rheumatoid arthritis: the dark horse of the augmented cardiovascular risk.

Authors:  Aliki I Venetsanopoulou; Eleftherios Pelechas; Paraskevi V Voulgari; Alexandros A Drosos
Journal:  Rheumatol Int       Date:  2020-06-10       Impact factor: 2.631

Review 2.  Vascular adhesion molecules in atherosclerosis.

Authors:  Elena Galkina; Klaus Ley
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-08-02       Impact factor: 8.311

3.  Patterns of cardiovascular risk in rheumatoid arthritis.

Authors:  D H Solomon; N J Goodson; J N Katz; M E Weinblatt; J Avorn; S Setoguchi; C Canning; S Schneeweiss
Journal:  Ann Rheum Dis       Date:  2006-06-22       Impact factor: 19.103

4.  The relationship of soluble ICAM-1, VCAM-1, P-selectin and E-selectin to cardiovascular disease risk factors in healthy men and women.

Authors:  E Demerath; B Towne; J Blangero; R M Siervogel
Journal:  Ann Hum Biol       Date:  2001 Nov-Dec       Impact factor: 1.533

5.  Circulating cell adhesion molecules and death in patients with coronary artery disease.

Authors:  S Blankenberg; H J Rupprecht; C Bickel; D Peetz; G Hafner; L Tiret; J Meyer
Journal:  Circulation       Date:  2001-09-18       Impact factor: 29.690

6.  Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease.

Authors:  Elena Myasoedova; Cynthia S Crowson; Hilal Maradit Kremers; Veronique L Roger; Patrick D Fitz-Gibbon; Terry M Therneau; Sherine E Gabriel
Journal:  Ann Rheum Dis       Date:  2011-01-07       Impact factor: 19.103

Review 7.  Cell adhesion molecules in rheumatoid arthritis.

Authors:  D J Veale; C Maple
Journal:  Drugs Aging       Date:  1996-08       Impact factor: 3.923

Review 8.  Role of cell adhesion molecules and immune-cell migration in the initiation, onset and development of atherosclerosis.

Authors:  Zhang Chi; Alirio J Melendez
Journal:  Cell Adh Migr       Date:  2007-10-20       Impact factor: 3.405

Review 9.  Adhesion molecules and atherosclerosis.

Authors:  Stefan Blankenberg; Sandrine Barbaux; Laurence Tiret
Journal:  Atherosclerosis       Date:  2003-10       Impact factor: 5.162

Review 10.  Cardiovascular Risk Assessment and Therapeutic Implications in Rheumatoid Arthritis.

Authors:  Juli Halacoglu; Leticia A Shea
Journal:  J Cardiovasc Transl Res       Date:  2020-02-20       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.